Biocon Share Price Surges: Why Q3 Profit Jumped 475% to ₹144 Crore
Synopsis: Biocon Limited (NSE: BIOCON) reported a staggering 475% YoY surge in consolidated net profit to ₹144 Crore for Q3 FY26, supported by a 9% rise in operating revenue to ₹4,173 Crore. The sharp turnaround was driven by robust momentum in the Generics segment and the full integration of Biocon Biologics as a wholly-owned subsidiary. […]












